Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ronrydellon Dec 02, 2013 10:01am

255 Views

Post# 21959275

RE:RE:RE:RE:Have to say RVX/DM reminds me of a country western song....

Lot's of cumulative good news in the last 90 days...will investors sitting on the fence decide that's it's worth another roll or the dice and build up a position to be realized in 2014?

in the scheme of things, for those that play in the high risk space, we've never had in the history of this stock play, a ratio as favorable between price and and is what is currently known. check the information/price ratio from today back down to 2003.

A GREAT CASE TO LOOK AT RVX AGAIN AT THIS TIME IN HISTORY!

(All IMHO...not to be considered investment advice)

Bullboard Posts

Who, why, and what of the great "Crypto Surge"